verified SJR 1,397 · Q1

United States · Elsevier Inc.

workspace_premium Q1 — Hematology lock_open Open Access

Biology of Blood and Marrow Transplantation

Biology of Blood and Marrow Transplantation is a journal indexed in SJR in Hematology and Transplantation with an H index of 126. It has a price of 1260 €. It has an SJR impact factor of 1,397 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,397.

Biology of Blood and Marrow Transplantation focuses its scope in these topics and keywords: transplantation, cell, patients, hematopoietic, stem, allogeneic, graftversushost, cd, risk, time, ...

ISSN: 1083-8791

Publisher: Elsevier Inc.

Category: Hematology

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,397 Q1

H-index 126

Acceptance rate pie_chart

23% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

1.260 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

1,397

H-index

126

Docs (year)

Docs 3y

1179

Total refs

Cites 3y

4918

Citable 3y

1069

Cites/Doc 2y

4.24

Ref/Doc

8.0

Immediate OA

1260 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Autologous stem cell transplantation for small cell lung cancer

Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization

Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation

Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation

Depletion of CD34+ CD4+ cells in bone marrow from HIV-1-infected individuals

Defective anticarbohydrate antibody responses to naturally occurring bacteria following bone marrow transplantation

Cytotoxic T-Lymphocyte Antigen-4 Single Nucleotide Polymorphisms Are Not Associated with Outcomes after Unrelated Donor Transplantation: A Center for International Blood and Marrow Transplant Research Analysis

Correction of phenotype in a thalassemia mouse model using a nonmyeloablative marrow transplantation regimen

Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia

Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: The Fred Hutchinson Cancer Research Center experience

Chloroquine prevention of murine MHC-disparate acute graft-versus-host disease correlates with inhibition of splenic response to CpG oligodeoxynucleotides and alterations in T-cell cytokine production

c-Kit and CD38 are expressed by long-term reconstituting hematopoietic cells present in the murine yolk sac

SHOW MORE ARTICLES

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: Comparative toxicity and outcomes

"Nonmyeloablative regimen preserves ""niches"" allowing for peripheral expansion of donor T-cells"

Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation

An Assay for Human Hematopoietic Stem Cells Based on Transplantation into Nonobese Diabetic Recombination Activating Gene-Null Perforin-Null Mice

Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections

Administration of daniplestim and granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in nonhuman primates

A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger

A Phase Ib Clinical Trial of PV701, a Milk-Derived Protein Extract, for the Prevention and Treatment of Oral Mucositis in Patients Undergoing High-Dose BEAM Chemotherapy

A Phase I/II Study of Mycophenolate Mofetil in Combination with Cyclosporine for Prophylaxis of Acute Graft-versus-Host Disease after Myeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation

A novel four-drug ablative regimen with hemopoietic stem cell rescue for patients with breast cancer: A phase II study

A human-murine chimera model for in utero human hematopoietic stem cell transplantation

FAQs

Biology of Blood and Marrow Transplantation has an SJR of 1,397 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 1260 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Biology of Blood and Marrow Transplantation is 23%.

Biology of Blood and Marrow Transplantation

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Biology of Blood and Marrow Transplantation?

What is the APC / publication cost?

What is the acceptance rate?